AIImpactLab
9 impact clustersWork & marketsCognition & learningTechnical failuresPrivacySecurityEnvironmentLaw & informationSocial good & healthSystemic risk
Search the evidence

Find the signal.

Search titles, impact clusters, countries, organizations and the full text of every analysis.

11 stories found

Cognition & learningGlobal+2 clusters01

Souei et al., “Artificial intelligence in deep brain stimulation for movement disorders: a systematic review and technology readiness assessment”

Researchers reviewed 239 peer-reviewed studies on AI-supported deep-brain stimulation and found a pronounced gap between reported algorithmic performance and clinical readiness. External validation remained rare, evaluations were predominantly retrospective and single-centre, and more than one-quarter of studies used small, high-dimensional datasets with elevated overfitting risk; most systems therefore remained at early-to-intermediate technology-readiness levels.

2 min
Technical failuresUnited Kingdom+3 clusters02

UK DSIT, “Thematic Review and Gap Analysis on AI Security”

The Department for Science, Innovation and Technology published an independent Lancaster University review that mapped 9,109 peer-reviewed AI-security papers from 2021 through January 2026 across 12 lifecycle themes. Despite rapid publication growth, the review identifies major blind spots in formal verification of training data and model-weight integrity, third-party model provenance, the interaction between AI-specific and conventional IT attack surfaces, end-user and shadow-AI risks, and secure retirement or disposal of frontier models.

2 min
A radiology scan passes through separate European and United States regulatory gates while two clocks show sharply different waits and shared evidence remains visible between them.
Social good & healthEuropean Union and United States+2 clusters03

Radiology AI faces a 14-month transatlantic approval gap

A peer-reviewed npj Digital Medicine study analyzed 239 AI-enabled radiology software devices with a European CE mark, United States Food and Drug Administration clearance, or both. Of the sample, 128 had only a CE mark, 95 received a CE mark before FDA clearance, and 16 received FDA clearance first. Among dual-authorized devices, the median wait for the second authorization was 17.5 months when the CE mark came first, compared with 3.5 months when FDA clearance came first. Radiograph-interpretation software was associated with a longer wait, while European Class IIa classification was associated with a shorter interval. The observational study identifies sequencing and association; it does not establish why every delay occurred or that one regulator's decision is superior. Its policy value is the asymmetry. Developers, hospitals, and regulators need clearer, comparable evidence requirements so validated safety information can travel across jurisdictions without converting coordination into weaker scrutiny.

5 min
A miniature patient moves through clinic, pharmacy, and payment gates while an oversized platform hand redirects the healthcare pathway.
Social good & healthGlobal+3 clusters04

Consumer AI is becoming healthcare's front door and traffic controller

A peer-reviewed Nature Health Perspective argues that consumer health AI is shifting from an information tool toward control of the care pathway. Major platforms are connecting health-oriented language models to medical records, appointment booking, pharmacy fulfilment, payments, and clinical workflows. The paper examines ChatGPT Health, Amazon Health AI, Ant Group's Afu, and Claude for Healthcare, and says public-health importance increasingly depends on platform integration depth rather than model performance alone. Deeper integration could help patients complete care, especially where services are fragmented or resource constrained. It can also concentrate triage power and create new asymmetries in data and operational control. The proposed accountability framework focuses on evaluation, procurement, routing transparency, data governance, and exit options. Regulators should follow the entire pathway: who interprets symptoms, ranks providers, sees the record, takes payment, and lets a patient leave.

5 min
A print table filled with biomedical papers reveals patterned AI fingerprints across discussion and results sections beside a clear preprint and provenance warning.
Law & informationGlobal research corpus+3 clusters05

Almost nine in ten late-2025 biomedical papers showed signs of AI-assisted writing

A preprint analyzed more than one million English-language open-access biomedical papers and estimated that 89 percent of papers published in December 2025 showed signs of some large-language-model-assisted writing. Nature reports estimates of 77 percent for 2025 overall and 52 percent for 2024, with signs appearing more often in discussions than results. The number is startling and easy to misuse. It does not mean AI authored 89 percent of biomedical papers, fabricated their data, or influenced the entire scientific literature. The method detects shifts in vocabulary within a specific PubMed Central corpus, the paper has not been peer reviewed, and other researchers told Nature that representativeness and methodology need further analysis. The finding still matters because AI assistance is moving from exceptional to ordinary while disclosure, attribution, data verification, citation checking, and journal policy remain inconsistent. Science needs provenance that distinguishes language editing from analysis, protects responsibility for claims, and lets readers audit the contribution without treating every polished sentence as misconduct.

5 min
A wall of 1,357 medical-device approval tiles narrows to three illuminated patient-outcome records beside an empty hospital evidence chart.
Social good & healthUnited States · Global implications+3 clusters06

Only three of 1,357 FDA-authorized AI medical devices were evaluated on patient outcomes

A PLOS Digital Health evidence census linked the FDA's 1,357 authorized AI and machine-learning medical devices through December 5, 2025 to prospective trials and publications. Thirty-four devices were linked to registered prospective trials, 12 had posted results, 12 had peer-reviewed publications, and only three evaluated patient-centered outcomes such as mortality, morbidity, or readmission. The review does not show that the remaining devices are ineffective; it shows that authorization and benchmark performance rarely answer the outcome question patients care about most. With 78 percent of the devices concentrated in radiology and vulnerable populations often excluded from studies, the validation gap can travel through hospitals and across countries long before durable benefit or equitable performance is known.

5 min
A human mathematician confronts a towering cascade of elegant artificial intelligence proofs, with hidden false steps glowing red beneath the chalk equations.
Cognition & learningGlobal+4 clusters07

Mathematicians warn AI could flood the proof economy with confident errors faster than humans can check them

The International Mathematical Union has endorsed the Leiden Declaration on Artificial Intelligence and Mathematics, according to Ars Technica. The declaration warns that AI can produce plausible but unreliable arguments, overwhelm peer review with cheap incorrect drafts, obscure attribution, distort hiring and funding, and let commercial announcements outrun independent evaluation. The warning is not a rejection of computational tools or proof assistance. It is a defense of the conditions that make mathematics trustworthy: disclosure, reproducibility, human responsibility, credit, and access to enough information for independent scrutiny. A machine may produce a correct result, but if the model, prompts, training data, compute, and method remain inaccessible, the community cannot easily determine what was learned, what can be reproduced, or whether a benchmark is being marketed as general reasoning.

5 min
Medical journal editors draw a red boundary between an artificial intelligence writing system and clinical images, references, opinions, and peer-review files.
Law & informationGlobal+3 clusters08

JAMA draws a hard line on AI authorship to protect medicine from fabricated authority

JAMA has updated its guidance for author use of artificial intelligence in medical publishing. AI may assist with research and manuscript preparation when the use is fully described and authors verify and accept responsibility for the content. The journal now advises authors not to use AI to generate or format references because realistic-looking citations may not exist. It also does not permit AI drafting of opinion manuscripts, letters, or online comments, and bars AI-created or manipulated clinical images, illustrations, video, and audio unless they are part of a formal research design or method that is fully disclosed. Peer-review use remains prohibited because submitting confidential manuscripts to external models can violate confidentiality. The policy is not an anti-AI ban. It draws responsibility lines where fluency, synthetic evidence, or automated authority could corrupt a clinical and scholarly record that patients and professionals rely on.

5 min
A corporate AI token meter is compared with an employee profile, pull requests, performance scores, and a rapidly changing cost dashboard.
Work & marketsUnited States+4 clusters09

Rippling cut AI token costs by routing work. Now it wants to score employee ROI

Rippling says unchecked AI spending grew 80 percent month over month and put it on a path to spend 40 percent of its research-and-development headcount budget on tokens. The company found that roughly 10 to 15 percent of employees drove about 60 percent of total AI spend, with one engineer spending $50,000 in a month. It then capped tools, routed tasks through cheaper models, connected usage to work outputs, and says the projected burden fell to 10 to 15 percent of the headcount budget without reducing overall token use. Those are vendor-reported results, not independent evidence. The new AI Spend Console extends that logic to customers by mapping individual and team costs against pull requests, performance ratings, rework, and other outputs. Cost control is sensible. Turning token consumption and imperfect productivity proxies into employee scores requires strict purpose limits, transparency, and appeal.

5 min
A strand of artificial intelligence code becomes a bacteriophage above a laboratory petri dish, marking the transition from digital design to living replication.
Social good & healthUnited States+4 clusters10

Scientists used AI to design viable viruses. The safety boundary just crossed into biology

Scientists used genome language models to design 16 viable bacteriophages that infected and killed the bacterium E coli in laboratory tests. The New York Times reports the peer-reviewed publication of work in which researchers generated thousands of candidate genomes, synthesized 285 designs, and identified 16 functional phages. These are viruses that target bacteria, not humans; Arc Institute says the models excluded eukaryotic viruses from training and the working phages showed restricted host range in testing. The result is both a therapeutic opportunity and a dual-use warning. AI-assisted phage design could help attack antibiotic-resistant bacteria, but it also proves that generative output can become a replicating biological system once synthesis and experimentation enter the chain.

5 min